Back to UBS Group AG UBS Group AG

GLTOGLTO
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in DAMORA THERAPEUTICS INC

UBS Group AG holds 840,292 shares of GLTO (DAMORA THERAPEUTICS INC), worth $21.9M as of 2026-Q2. The position was increased (+423.8% shares). GLTO represents 0.0% of UBS Group AG's portfolio.

Current Value

$21.9M

Current Shares

840,292

Total Value Change

+$21.8M

Total Shares Change

+835,193

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
840,292
+423.8%
$21.9M0.0%$28.08
46
2026-Q1
Increased
160,415
+2410.8%
$4.2M0.0%$28.08
43
2025-Q4
Increased
6,389
+107x
$147,0110.0%$22.31
25
2025-Q3
Decreased
59
-97.5%
$2200.0%$3.80
0
2025-Q2
Increased
2,313
+711.6%
$7,8870.0%$3.42
18
2025-Q1
Decreased
285
-97.7%
$8830.0%$3.42
0
2024-Q4
Increased
12,467
+144.5%
$57,9720.0%$4.60
23
2024-Q3
New
5,099
-
$61,9530.0%$11.71
32

Other major holders of GLTO: FMR LLC, Avoro Capital Advisors LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used